IMMUNITYBIO INC's ticker is and the CUSIP is 45256X953. A total of 4 filers reported holding IMMUNITYBIO INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,885 | -52.5% | 16,500 | -21.8% | 0.00% | – |
| Q2 2023 | $58,658 | +61.1% | 21,100 | +5.5% | 0.00% | – |
| Q1 2023 | $36,400 | -92.5% | 20,000 | -79.1% | 0.00% | – |
| Q4 2022 | $485,199 | -22.6% | 95,700 | -24.1% | 0.00% | – |
| Q3 2022 | $627,000 | +335.4% | 126,100 | +225.0% | 0.00% | – |
| Q2 2022 | $144,000 | – | 38,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NATIONAL BANK OF CANADA /FI/ | 1,303 | $660,621 | 0.00% |
| GROUP ONE TRADING, L.P. | 73,800 | $374,166 | 0.00% |
| SIMPLEX TRADING, LLC | 19,400 | $98 | 0.00% |
| JANE STREET GROUP, LLC | 95,700 | $485,199 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |